CD80 extracellular domain Fc fusion proteins for treating PD-L1 negative tumors
US-12589132-B2 · Mar 31, 2026 · US
Five Prime Therapeutics Inc holds 145 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 145 |
| Recent patents | 33 |
| First publication | Feb 10, 2015 |
| Latest publication | Mar 31, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12589132-B2 · Mar 31, 2026 · US
US-2026085123-A1 · Mar 26, 2026 · US
US-2026049114-A1 · Feb 19, 2026 · US
US-12465636-B2 · Nov 11, 2025 · US
US-12435145-B2 · Oct 7, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12589132-B2 · Mar 31, 2026 · US
US-2026085123-A1 · Mar 26, 2026 · US
US-2026049114-A1 · Feb 19, 2026 · US
US-12465636-B2 · Nov 11, 2025 · US
US-12435145-B2 · Oct 7, 2025 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P35/00 | 123 |
| A61K2039/505 | 91 |
| C07K2317/92 | 78 |
| A61K45/06 | 73 |
| C07K2317/76 | 66 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 139 |
| Chemistry & Metallurgy | 138 |
| Physics | 39 |
| Cross-Sectional Technologies | 5 |
| Operations & Transport | 3 |
Answers are generated from the same data shown on this page.